Tuesday, October 4, 2022

561.316.3330

Biotechnology News Magazine

Global RNA-based Therapeutics and Vaccines Market Trajectory & Analytics Report 2021: Market to Reach $499 Million by 2027 – Therapeutics to Grow at a CAGR of 68.1% and Reach $372.5 Million

Latest Posts

City of Hope to Accelerate Immunotherapy Research & Treatment Innovation with $15 Mil Gift from Ted Schwartz Family

Ted Schwartz, who is now cancer free, achieved complete remission at City of Hope in 2020 with the center's leading CAR T cell therapy after a 16-year battle with lymphoma, provided the gift to City of Hope to advance treatment options that offer better outcomes and quality of life for people living with cancer.

Neurocrine Biosciences Appoints Dr Ingrid Delaet as Chief Regulatory Officer

Prior to joining Neurocrine Biosciences, Dr Ingrid Delaet served as Senior Vice President, Regulatory Affairs at Intercept Pharmaceuticals, which she joined in 2016.

Astrea Bioseparations Introduces Nereus LentiHERO, a Fit-for-purpose Solution for Lentiviral Vector Purification

“We believe that AstreAdept will be a game-changer,” explained Astrea Bioseparations’ CEO Terry Pizzie. “Our approach was to rapidly develop and incorporate this material into the Nereus LentiHERO, a simple, fit-for-purpose device that radically transforms how lentivirus can be purified [in terms of speed, recovery, and efficiency].

At Pack Expo, Schreiner MediPharm to Debut Functional Labels Designed from More Sustainable Materials

Schreiner MediPharm advises he new label concepts are based on existing items in Schreiner MediPharm’s roster of functional labeling solutions.

Global RNA-based Therapeutics and Vaccines Market: The “RNA-based Therapeutics and Vaccines – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.

Global RNA-based Therapeutics and Vaccines Market to Reach $499 Million by 2027

Amid the COVID-19 crisis, the global market for RNA-based Therapeutics and Vaccines estimated at US$14.7 Million in the year 2020, is projected to reach a revised size of US$499 Million by 2027, growing at a CAGR of 65.5% over the period 2020-2027.

RNA-based Therapeutics, one of the segments analyzed in the report, is projected to record 68.1% CAGR and reach US$372.5 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the RNA-based Vaccines segment is readjusted to a revised 59.2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $4.5 Million, While China is Forecast to Grow at 62% CAGR

The RNA-based Therapeutics and Vaccines market in the U.S. is estimated at US$4.5 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$76.6 Million by the year 2027 trailing a CAGR of 62% over the analysis period 2020 to 2027.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 59.2% and 55.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 43.7% CAGR.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS (Total 41 Featured):

  • Alnylam Pharmaceuticals, Inc.
  • Arbutus Biopharma Corporation
  • Arrowhead Pharmaceuticals, Inc.
  • BioNTech AG
  • CureVac AG
  • Dicerna Pharmaceuticals, Inc.
  • Marina Biotech, Inc.
  • miRagen Therapeutics, Inc.
  • Moderna, Inc.
  • Quark Pharmaceuticals, Inc.
  • Regulus Therapeutics, Inc.
  • Sylentis S.A.

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • World Current & Future Analysis for RNA-based Therapeutics and Vaccines by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • World Current & Future Analysis for RNA-based Therapeutics by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • World Current & Future Analysis for RNA-based Vaccines by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • World Current & Future Analysis for Oncology by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • World Current & Future Analysis for Immunology by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • World Current & Future Analysis for Ophthalmology by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • World Current & Future Analysis for Cardiovascular Diseases by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • World Current & Future Analysis for Infectious Diseases by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • World Current & Future Analysis for Genetic Diseases by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR

III. GEOGRAPHIC MARKET ANALYSIS

IV. COMPETITION

  • Total Companies Profiled: 41

For more information about this report visit https://www.researchandmarkets.com/r/xhwm6k

 

Latest Posts

Learn More

spot_img

Subscribe

spot_img

Our Sister Publication

Medical Device News Magazine